Trade

with

Haemonetics Corp
(NYSE: HAE)
AdChoices
36.00
+0.56
+1.58%
After Hours :
36.00
0.00
0.00%

Open

35.44

Previous Close

35.44

Volume (Avg)

160.51k (246.98k)

Day's Range

35.44-36.15

52Wk Range

29.86-44.20

Market Cap.

1.82B

Dividend Rate ( Yield )

-

Beta

0.74

Shares Outstanding

51.43M

P/E Ratio (EPS)

47.17 (0.75)

AdChoices
Fundamentals
  • Key statistics
  • Growth
  • Profitability
  • Financial health
  • Price ratios
  • Trading statistics
  • Management effectiveness
Industry Medical Instruments & Supplies
Highlights
Analyst Recommendation: Outperform
    • Revenue

    • 938.51M

    • Net Income

    • 35.15M

    • Market Cap.

    • 1.82B

    • Enterprise Value

    • -

    • Net Profit Margin %

    • 4.17

    • PEG (Price/Earnings Growth) Ratio

    • 1.47

    • Beta

    • 0.74

    • Forward P/E

    • 19.05

    • Price/Sales

    • 2.00

    • Price/Book Value

    • 2.27

    • Price/Cash flow

    • 13.51

      • EBITDA

      • 129.07M

      • Return on Capital %

      • 2.66

      • Return on Equity %

      • 4.95

      • Return on Assets %

      • 2.66

      • Book Value/Share

      • 15.85

      • Shares Outstanding

      • 51.43M

      • Last Split Factor (Date)

      • -

      • Last Dividend (Ex-Date)

      • -

      • Dividend Declaration Date

      • -

      Analyst Recommendation
      10/21/2014
      Outperform
        • 1 Year Price Target

        • 40.33

        • Credit Rating

        • -

        • Analysts

        • 3

        • EPS Estimate

        • 0.36

        • Cashflow Estimate

        • -

        Morningstar Consensus estimate data
        • Growth Rate (%)

        • Company

        • Industry

          • Sales (Revenue)

            Q/Q (last year)

          • 2.30

          • 10.42

          • Net Income

            YTD/YTD (last year)

          • -9.40

          • -15.59

          • Net Income

            Q/Q (last year)

          • -

          • -8.93

          • Sales (Revenue)

            5-Year Annual Average

          • 9.44

          • 12.51

          • Net Income

            5-Year Annual Average

          • -9.90

          • 4.16

          • Dividends

            5-Year Annual Average

          • -

          • 0.97

          • Profit Margins (%)

          • Company

          • Industry

            • Gross Margin

            • 49.10

            • 52.83

            • Pre-Tax Margin

            • 4.39

            • 15.96

            • Net Profit Margin

            • 4.17

            • 12.40

            • Average Gross Margin

              5-Year Annual Average

            • 50.70

            • 52.66

            • Average Pre-Tax Margin

              5-Year Annual Average

            • 10.10

            • 18.40

            • Average Net Profit Margin

              5-Year Annual Average

            • 7.60

            • 93.46B

            • Financial Ratios

            • Company

            • Industry

              • Debt/Equity Ratio

              • 0.53

              • 0.62

              • Current Ratio

              • 3.43

              • 1.97

              • Quick Ratio

              • 1.79

              • 1.16

              • Interest Coverage

              • -

              • 10.47

              • Leverage Ratio

              • 1.81

              • 2.38

              • Book Value/Share

              • 15.85

              • 12.15

              • Price Ratios

              • Company

              • Industry

                • Current P/E Ratio

                • 48.08

                • 36.10

                • P/E Ratio 5-Year High

                • 61.21

                • 279.08

                • P/E Ratio 5-Year Low

                • 33.67

                • 148.87

                • Price/Sales Ratio

                • 2.00

                • 3.37

                • Price/Book Value

                • 2.27

                • 4.21

                • Price/Cash Flow Ratio

                • 13.51

                • 17.42

                • Key Metrics

                • Company

                  • Shares Short

                    as of -

                  • -

                  • Short Ratio

                    as of -

                  • -

                  • Short % of Float

                    as of -

                  • -

                  • Shares Short

                    prior month

                  • -

                  • Trailing Annual Dividend Yield

                  • -

                  • 5 Year Average Dividend Yield

                  • -

                  • Key Metrics

                  • Company

                    • Payout Ratio

                    • -

                    • Dividend Date

                    • -

                    • Ex-Dividend Date

                    • -

                    • Last Split Factor

                      new per old

                    • -

                    • Last Split Date

                    • -

                    • Key Metrics

                    • Company

                    • Industry

                      • Return on Equity %

                        (5-Year Average)

                      • 4.95

                        (8.40)

                      • 17.93

                        (21.42)

                      • Return on Assets %

                        (5-Year Average)

                      • 2.66

                        (6.30)

                      • 7.35

                        (9.50)

                      • Return on Capital %

                        (5-Year Average)

                      • 3.15

                        (7.70)

                      • 10.24

                        (13.59)

                      • Income/Employee

                      • 10.41k

                      • 25.65k

                      • Inventory Turnover

                      • 2.38

                      • 2.66

                      • Asset Turnover

                      • 0.64

                      • 0.59

                      Current Historical
                      Financials
                      • Income Statement
                      • Balance Sheet
                      • Cash Flow
                      Operating Income
                      47.33M
                      Operating Margin
                      5.04
                      Total Equity
                      -
                      Retained Earnings
                      -
                      Free Cashflow
                      -
                      Price/Cashflow
                      13.51
                      Ownership

                      Institutional Ownership

                      -

                      Top 10 Institutions

                      44.58%

                      Mutual Fund Ownership

                      58.65%

                      Float

                      88.40%

                      5% / Insider Ownership

                      1.05%

                      Corporate insiders or major stockholders reporting trading activity in the stock.

                      Top Mutual Fund Owners

                      Top Institutional Owners

                      Mutual Fund Name

                      Institution Name

                      • Mutual Fund Name

                      • Shares Held

                      • % Change

                      • % Outstanding

                      • Neuberger Berman Genesis Fund

                      •  

                        4,493,600

                      • -2.17

                      • 8.74

                      • Fidelity Small Cap America Class

                      •  

                        1,315,100

                      • 8.23

                      • 2.73

                      • CI Black Creek Global Leaders

                      •  

                        1,151,969

                      • 0.00

                      • 2.24

                      • iShares Core S&P Small-Cap (AU)

                      •  

                        1,038,682

                      • 0.20

                      • 2.05

                      • Franklin Growth Fund

                      •  

                        1,000,000

                      • 0.00

                      • 1.94

                      • Vanguard Small Cap Index

                      •  

                        894,324

                      • -1.44

                      • 1.74

                      • Vanguard Total Stock Mkt Idx

                      •  

                        851,486

                      • 0.57

                      • 1.66

                      • iShares Russell 2000 (AU)

                      •  

                        774,976

                      • -1.46

                      • 1.53

                      • American Beacon Small Cap Value Fund

                      •  

                        770,469

                      • 0.00

                      • 1.50

                      • Cambiar Small Cap Fund

                      •  

                        707,000

                      • 0.00

                      • 1.37

                      • Institution Name

                      • Shares Held

                      • % Change

                      • % Outstanding

                      • Neuberger Berman LLC

                      •  

                        5,522,650

                      • -2.72%

                      • 10.74

                      • Vanguard Group, Inc.

                      •  

                        3,465,654

                      • -2.06%

                      • 6.74

                      • Barrow, Hanley, Mewhinney & Strauss LLC.

                      •  

                        2,926,524

                      • -3.82%

                      • 5.69

                      • BlackRock Fund Advisors

                      •  

                        2,728,327

                      • -5.68%

                      • 5.30

                      • Fidelity Management and Research Company

                      •  

                        1,475,454

                      • +5.19%

                      • 2.87

                      • Wellington Management Company, LLP

                      •  

                        1,464,691

                      • +72.04%

                      • 2.85

                      • Van Berkom and Associates Inc.

                      •  

                        1,346,269

                      • +6.99%

                      • 2.62

                      • M&G INVESTMENT MANAGEMENT LTD

                      •  

                        1,343,591

                      • -21.82%

                      • 2.61

                      Company Profile

                      Sector

                      Healthcare

                      Industry

                      Medical Instruments & Supplies

                      Type

                      Slow Growth

                      Style

                      Small Growth

                      Haemonetics Corp is a healthcare company that provides blood management solutions to its customers. Its portfolio of integrated devices, information management, and consulting services offers blood management solutions for each facet...more of the blood supply chain, helps improve clinical outcomes and reduce costs for blood and plasma collectors, hospitals, and patients around the world. Its products and services help prevent a transfusion to a patient who does not need one and provide the right blood product, at the right time, in the right dose to the patient who does. It serves three markets: manufacturers of plasma derived pharmaceuticals, blood collectors, and hospitals. Its product categories include: Plasma, Blood Center, Hospital, and Software Solutions. Plasma includes plasma collection devices a...morend consumables. Blood Center includes blood collection and processing devices and consumables. Hospital includes surgical blood salvage and blood demand diagnostic devices and consumables. Software Solutions includes information technology platforms and consulting services provided to all three markets. The products it manufactures and markets are subject to regulation by the Center of Biologics Evaluation and Research and the Center of Devices and Radiological Health of the United States Food and Drug Administration, and other non-United States regulatory bodies.lessless

                      Key People

                      Brian P. Concannon

                      Director/President/CEO

                      Richard J. Meelia

                      Chairman of the Board/Director

                      Mr. Christopher J. Lindop

                      CFO/Vice President, Divisional

                      Brian R. Burns

                      Executive VP, Divisional

                      Dave Helsel

                      Executive VP, Divisional

                      • Haemonetics Corp

                      • 400 Wood Road

                      • Braintree, MA 02184-9114

                      • USA.Map

                      • Phone: +1 781 848-7100

                      • Fax: -

                      • haemonetics.com

                      Incorporated

                      1971

                      Employees

                      3,782

                      Send Feedback

                      We appreciate your input!

                      • I'm having trouble signing into my Microsoft account

                      • I’m having problems with the services stripe (Mail, Facebook, etc.)

                      • There is an issue with my weather information

                      • I see an error in the content

                      • Other

                      Please give an overall site rating: